139 related articles for article (PubMed ID: 38296711)
1. Molecular landscape of proliferative verrucous leukoplakia: a systematic review.
Nissanka-Jayasuriya EH; Fenton TR; Rose-Zerilli MJJ
Br J Oral Maxillofac Surg; 2024 Feb; 62(2):118-127. PubMed ID: 38296711
[TBL] [Abstract][Full Text] [Related]
2. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
[TBL] [Abstract][Full Text] [Related]
3. Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms.
Farah CS; Shearston K; Turner EC; Vacher M; Fox SA
Oral Oncol; 2024 Apr; 151():106737. PubMed ID: 38408418
[TBL] [Abstract][Full Text] [Related]
4. Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
Herreros-Pomares A; Llorens C; Soriano B; Bagan L; Moreno A; Calabuig-Fariñas S; Jantus-Lewintre E; Bagan J
Oral Oncol; 2021 May; 116():105191. PubMed ID: 33657465
[TBL] [Abstract][Full Text] [Related]
5. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
6. Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features.
Herreros-Pomares A; Hervás D; Bagan-Debon L; Proaño A; Garcia D; Sandoval J; Bagan J
Oral Dis; 2024 Apr; 30(3):1072-1083. PubMed ID: 36892444
[TBL] [Abstract][Full Text] [Related]
7. Wolf in sheep's clothing - Oral proliferative verrucous leukoplakia: Progression with longitudinal molecular insights.
Afkhami M; Maghami E; Gernon TJ; Villaflor V; Bell D
Ann Diagn Pathol; 2023 Apr; 63():152104. PubMed ID: 36640643
[TBL] [Abstract][Full Text] [Related]
8. Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma.
Lombardi N; Varoni EM; Franchini R; Lodi G
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967933
[TBL] [Abstract][Full Text] [Related]
9. Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development.
Llorens C; Soriano B; Trilla-Fuertes L; Bagan L; Ramos-Ruiz R; Gamez-Pozo A; Peña C; Bagan JV
Clin Oral Investig; 2021 May; 25(5):2645-2657. PubMed ID: 32918120
[TBL] [Abstract][Full Text] [Related]
10. Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.
Bagan L; Sáez GT; Tormos MC; Labaig-Rueda C; Murillo-Cortes J; Bagan JV
Clin Oral Investig; 2016 May; 20(4):737-43. PubMed ID: 26254143
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Biomarkers in Oral Verrucous Carcinoma: A Systematic Review.
Hosseinpour S; Mashhadiabbas F; Ahsaie MG
Pathol Oncol Res; 2017 Jan; 23(1):19-32. PubMed ID: 27924463
[TBL] [Abstract][Full Text] [Related]
12. Proliferative verrucous leukoplakia. Four cases with flow cytometric analysis.
Kahn MA; Dockter ME; Hermann-Petrin JM
Oral Surg Oral Med Oral Pathol; 1994 Oct; 78(4):469-75. PubMed ID: 7800379
[TBL] [Abstract][Full Text] [Related]
13. Prognostic outcomes of oral squamous cell carcinoma derived from proliferative verrucous leukoplakia: A systematic review.
Faustino ISP; de Pauli Paglioni M; de Almeida Mariz BAL; Normando AGC; Pérez-de-Oliveira ME; Georgaki M; Nikitakis NG; Vargas PA; Santos-Silva AR; Lopes MA
Oral Dis; 2023 May; 29(4):1416-1431. PubMed ID: 35199416
[TBL] [Abstract][Full Text] [Related]
14. Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia.
Koh J; Kurago ZB
Head Neck Pathol; 2019 Dec; 13(4):635-642. PubMed ID: 30888638
[TBL] [Abstract][Full Text] [Related]
15. [Gene expression profile changes in oral verrucous carcinoma and oral squamous cell carcinoma].
Tang ZG; Zhao SP; Zhang L; Li XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Apr; 42(4):229-30. PubMed ID: 17683672
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases.
Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L
Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646
[TBL] [Abstract][Full Text] [Related]
17. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
18. A novel genomic signature reclassifies an oral cancer subtype.
Samman M; Wood HM; Conway C; Stead L; Daly C; Chalkley R; Berri S; Senguven B; Ross L; Egan P; Chengot P; Ong TK; Pentenero M; Gandolfo S; Cassenti A; Cassoni P; Al Ajlan A; Samkari A; Barrett W; MacLennan K; High A; Rabbitts P
Int J Cancer; 2015 Nov; 137(10):2364-73. PubMed ID: 26014678
[TBL] [Abstract][Full Text] [Related]
19. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
[TBL] [Abstract][Full Text] [Related]
20. Oral Proliferative Verrucous Leukoplakia: Progression to Malignancy and Clinical Implications. Systematic Review and Meta-Analysis.
Palaia G; Bellisario A; Pampena R; Pippi R; Romeo U
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
